JENNIFER TAYLOR: Open Payments
NPI 1245858018 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 25 payments from 6 companies in 2025. Trend: 2023 $367 · 2024 $1,107 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $198 |
| AstraZeneca Pharmaceuticals LP | 3 | $161 |
| ABBVIE INC. | 12 | $143 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| PFIZER INC. | 2 | $31 |
| COLOPLAST CORP | 1 | $14 |
Products named: Ozempic, AIRSUPRA, NUZYRA, QULIPTA, UBRELVY, VRAYLAR, Wegovy, BREZTRI.
Industry payments across OK — which companies pay providers there.
